Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months
dc.contributor.author | Zimmerman, Richard K | |
dc.contributor.author | Hoberman, Alejandro | |
dc.contributor.author | Nowalk, Mary Patricia | |
dc.contributor.author | Lin, Chyongchiou J | |
dc.contributor.author | Greenberg, David P | |
dc.contributor.author | Weinberg, Stuart T | |
dc.contributor.author | Bemm, Charles W | |
dc.contributor.author | Block, Bruce | |
dc.date.accessioned | 2019-08-14T14:59:24Z | |
dc.date.available | 2019-08-14T14:59:24Z | |
dc.date.issued | 2004 | |
dc.description.abstract | Background: Annual influenza-related hospitalization rates of children aged <2 years in the United States are second only to those of the elderly. Yet no recommendations existed for vaccinating healthy children aged 6 to 23 months until 2002, when the Advisory Committee on Immunization Practices encouraged influenza vaccination for them. This study tested the feasibility of vaccinating 6- to 23-month-old children against influenza and assessed the effect on timely receipt of other vaccines. Methods: A pre–post trial was used in urban health centers serving low-income children. Sites selected interventions from strategies proven to increase vaccination rates. Targeted patients were aged 6 to 23 months by November 30, 2002 (N=1534). Results: Influenza vaccination rates for the 2002–2003 intervention season improved significantly from 6.5% to 38.5% for the first dose (p <0.001). Second-dose rates were significantly improved over preintervention (1.9% preintervention, 13.2% intervention), but lower than first-dose rates. Mean ages at vaccination for other recommended childhood vaccines did not differ or were significantly younger (measles, mumps, and rubella vaccine [MMR] and varicella) for children who received influenza vaccine versus those who did not. Moreover, a higher percentage of influenza-vaccinated than unvaccinated children received MMR, diphtheria, tetanus, pertussis vaccine 3 (DTaP3), inactivated poliovirus vaccine 2 (IPV2), and Haemophilus influenzae b (Hib2) vaccines within a 2-month grace period of the recommended age (p <0.039), with no differences between groups for Hib1, DTaP1, IPV1, and varicella. Conclusions: With directed effort, it is possible to increase influenza vaccination at health centers serving low-income children. The addition of a two-dose vaccine was not associated with delayed receipt of other vaccines among these children. | |
dc.description.uri | https://www.ajpmonline.org/article/S0749-3797(04)00193-X/abstract | |
dc.identifier | https://doi.org/10.13016/z0w8-bmqj | |
dc.identifier.citation | Zimmerman, Richard K and Hoberman, Alejandro and Nowalk, Mary Patricia and Lin, Chyongchiou J and Greenberg, David P and Weinberg, Stuart T and Bemm, Charles W and Block, Bruce (2004) Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months. American Journal of Preventive Medicine, 27 (5). pp. 397-403. | |
dc.identifier.issn | 07493797 | |
dc.identifier.other | Eprint ID 471 | |
dc.identifier.uri | http://hdl.handle.net/1903/22564 | |
dc.subject | Access To Healthcare | |
dc.subject | Health | |
dc.subject | Practice | |
dc.subject | Research | |
dc.subject | influenza | |
dc.subject | flu | |
dc.subject | immunization | |
dc.subject | inner-city | |
dc.subject | urban | |
dc.subject | children | |
dc.title | Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months | |
dc.type | Article |